IMMUNOMODULATING THERAPY BY RECOMBINANT ALPHA-2B INTERFERON AMONG CHILDREN WITH TIMOMEGALIA
Abstract
The study of the enlarged thymus gland syndrome is extremely important for understanding of the immune system formation and functioning mechanisms. the purpose of this study is to conduct clinical and immunological analysis of the children, suffering from the syndrome of the enlarged thymus gland II and III degrees, who received recombinant alpha2b interferon (in suppositories). The revealed changes in the immune sys tem during timomegalia are complex and conducive to the development of the infectious and inflammatory diseases among infants, thus, determining the necessity for the adequate immune correction. The application of the recombinant alpha 2b interferon among such children allows one to uncover the immunomodulating effects, normalizing the imbalances in the immune system of children with timomegalia.
Key words: timomegalia, alpha 2b interferon, immunity, immune correction, children.
About the Authors
L.A. Nikulin
Chair of Pediatrics with a course in neonatology, Advanced Training and Professional Retraining Faculty, Kuban' State Medical University
Russian Federation
M.G. Kulagina
Chair of Pediatrics with a course in neonatology, Advanced Training and Professional Retraining Faculty, Kuban' State Medical University
Russian Federation
D.A. Kayumova
Chair of Pediatrics with a course in neonatology, Advanced Training and Professional Retraining Faculty, Kuban' State Medical University
Russian Federation
E.V. Borovikova
Chair of Pediatrics with a course in neonatology, Advanced Training and Professional Retraining Faculty, Kuban' State Medical University
Russian Federation
For citations:
Nikulin L.,
Kulagina M.,
Kayumova D.,
Borovikova E.
IMMUNOMODULATING THERAPY BY RECOMBINANT ALPHA-2B INTERFERON AMONG CHILDREN WITH TIMOMEGALIA. Pediatric pharmacology. 2007;4(4):26-29.
Views:
635